Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Armourgel (now operating as RHEON Labs) is a materials science company specializing in energy-absorbing technology for healthcare and sports. Spun out from Imperial College London by Dr. Dan Plant, the company developed a proprietary shear-thickening polymer with an auxetic geometry that remains flexible during normal use but hardens instantly upon impact. Its primary medical application is a thin, wearable hip protector designed to prevent fractures in elderly and osteoporotic patients, a project supported by the NHS and the Royal Academy of Engineering. The technology is also widely used in high-performance sports equipment, such as helmets and body armor, to mitigate linear and rotational impact forces. The company's innovations have been recognized with numerous awards, including the Royal Academy of Engineering Enterprise Fellowship.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Armourgel.